<DOC>
	<DOCNO>NCT00699023</DOCNO>
	<brief_summary>The purpose study determine whether ezetimibe association statin effective statin alone postprandial lipemia type 2 diabetic patient .</brief_summary>
	<brief_title>Ezetimibe Statins Postprandial Lipemia Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Type 2 diabetes since least two year Stable metabolic control ( HbA1c &lt; 8.0 % ) least six month diet diet+oral hypoglycemic drug ( insulin secretagogues metformin ) , change study period . BMI &lt; 30 kg/m2 body weight stable last six month . Both sex ; postmenopausal woman . LDLcholesterol &gt; 130 mg/dl , plasma triglyceride &lt; 400 mg/dl . No use hypolipidemic drug last three month . Patient renal ( serum creatinine &gt; 1.5 mg/dl ) hepatic ( serum transaminase &gt; three time upper normal value ) impairment . Patients history cardiovascular disease . Premenopausal woman . Any acute chronic degenerative disease . Anemia ( Hb &lt; 12 g/dl ) . Uncontrolled blood pressure . Use drug able interfere study medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>postprandial lipemia</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>ezetimibe</keyword>
	<keyword>hypercholesterolemia</keyword>
</DOC>